anti-EphA2 monoclonal antibodies (MedImmune/Purdue)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameanti-EphA2 monoclonal antibodies (MedImmune/Purdue)
Drug Alias NameEphA2 tyrosine kinase inhibitor (MedImmune/Purdue)EA-5 (MedImmune)MEDI-531
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionEphrin type-A receptor 2 antagonistsAnticancer protein kinase inhibitorsMetastasis inhibitors
TargetsEphrin type-A receptor 2
Therapy Area/IndicationsNeoplasm MetastasisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPurdue University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPurdue UniversityMedimmune Llc
Active IndicationsN/A
Inactive IndicationsNeoplasm MetastasisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A